Abstract
Influenza infections have resulted in millions of deaths and untold millions of illnesses throughout history. Influenza vaccines are the cornerstone of influenza prevention and control. Recommendations are made by the World Health Organization (WHO) 6–9 months in advance of the influenza season regarding what changes, if any, should be made in the formulation of seasonal influenza vaccines. This allows time to manufacture, test, distribute, and administer vaccine prior to the beginning of the influenza season. At the same time experts also consider which viruses not currently circulating in the human population, but with pandemic potential, pose the greatest risk to public health. Experts may conclude that one or more of these viruses are of enough concern to warrant development of a high-growth reassortant candidate vaccine virus. Subsequently, national authorities may determine that a vaccine should be manufactured, tested in clinical trials, and even stockpiled in some circumstances. The Influenza Risk Assessment Tool (IRAT) was created in an effort to develop a standardized set of elements that could be applied for decision making when evaluating pre-pandemic viruses. The tool is a simple, additive model, based on multi-attribute decision analysis . The ultimate goal is to identify an appropriate candidate vaccine virus and prepare a human vaccine before the virus adapts to infect and efficiently transmit in susceptible human populations. This pre-pandemic preparation allows production of vaccine—a strategy that could save lives and mitigate illness during a pandemic.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- CDC:
-
Centers for Disease Control and Prevention
- HPAI:
-
Highly pathogenic avian influenza
- IRAT:
-
Influenza Risk Assessment Tool
- RVF:
-
Rift Valley fever
- SMEs:
-
Subject matter experts
- WHO:
-
World Health Organization
References
Anyamba A, Chretien JP, Small J, Tucker CJ, Formenty PB, Richardson JH, Britch SC, Schnabel DC, Erickson RL, Linthicum KJ (2010a) Prediction of a Rift Valley fever outbreak. PNAS 106(3):955–959
Anyamba A, Linthicum KJ, Small J, Britch SC, Pak E, de La Rocque S, Formenty P, Hightower AW, Breiman RF, Chretien JP, Tucker CJ, Schnabel D, Sang R, Haagsma K, Lathem M, Lewandowski HB, Magdi SO, Mohamed MA, Nguku PM, Reynes JM, Swanepoel R (2010b) Prediction, assessment of the Rift Valley fever activity in east and southern Africa 2006–2008 and possible vector control strategies. Am J Trop Med Hyg 83(Sup 2):43–51
Briet OJT, Vounatsou P, Gunawardena DM, Galappaththy GNL, Amerasinghe PH (2008) Models for short term malaria prediction in Sri Lanka. http://www.malariajournal.com/content/7/1/76
Britch SC, Binepal YS, Ruder MG, Kariithi HM, Linthicum KJ, Anyamba A, Small JL, Tucker CJ, Ateya LO, Oriko AA, Gacheru S, Wilson WC (2013) Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya. PLoS One 8(6):e66626
Centers for Disease Control and Prevention (2010) Interim results: Influenza A (H1N1) 2009 monovalent vaccination coverage—United States, October—December 2009. MMWR Morb Mortal Wkly Rep 59(02):44–48
Centers for Disease Control and Prevention (2009) Swine Influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 58(15):400–402
Dawood FS, Juliano AD, Reed C, Meltzer MI, Shay KD, Cheng PY, Dandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Molabak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet 12:651–653
Department of Health, Education and Welfare (1978) Interagency work group on pandemic influenza. A plan for pandemic influenza
Dolan JG (2010) Multi-criteria clinical decision support: a primer on the use of multiple criteria decision making methods to promote evidence based, patient centered healthcare. Patient 4:229–248
Edwards W, Barron FH (1994) SMARTS and SMARTER: improved simple methods for multi-attribute utility measurement. Organ Behav Hum Decis Process 60:306–325
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Guizhen W, Wang Y, Yuan Z, Shu Y (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. NEJM 368(20):1888–1897
Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graff M, Burke DF, Fouchier RAM, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Boxrud D, Sambol AR, Abid SH, St. George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201
Glezen WP (1996) Emerging infections: Pandemic influenza. Epidemio Rev 18(1):64–76
Homeland Security Council (2005) National strategy for pandemic influenza. http://www.flu.gov/planning-preparedness/federal/pandemic-influenza.pdf
Hoshen MB, Morse AP (2004) A weather-driven model of malaria transmission. http://www.malariajournal.com/content/3/1/32
OIE World Organisation for Animal Health (2014) Update on highly pathogenic avian influenza in animals (type H5 and H7) http://www.oie.int/animal-health-in-the-world/update-on-avian-influenza/2014/
Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC (2013) Pandemic influenza planning, United States, 1978–2008. EID 19(6):879–885
Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, Shively R, Brammer L, Burke SA, Villanueva JM, Balish A, Uyeki T, Mustaquim D, Bishop A, Handsfield JH, Astles R, Xu X, Klimov AI, Cox NJ, Shaw MW (2011) Detecting 2009 pandemic influenza A(H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. CID 52(Suppl 1):S36–S43
Jhung MA, Swerdlow D, Olson SJ, Jernigan D, Biggerstaff M, Kamimoto L, Kniss K, Reed C, Fry A, Brammer L, Gindler J, Gregg WJ, Bresee J, Finelli L (2011) Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. CID 52(Suppl 1):S13–S26
Kasowski EJ, Garten RJ, Bridges CB (2011) Influenza pandemic epidemiologic and virologic diversity: reminding ourselves of the possibilities. CID 52(Suppl 1):S44–S49
Metwally S (2008) Rift Valley fever. In; Brown C, Torres A (eds) Foreign animal diseases, 7th edn. USAHA, Boca Raton, pp 369–375
Morans DM, Fauci AS (2007) The 1918 influenza pandemic: insights for the 21st century. JID 195:1018–1028
Parry J (2013) H7N9 avian flu infects humans for the first time. BMJ 346:f2151
Phillips LD (1984) A theory of requisite decision models. Acta Psychologica 56:29–48
Schuchat A, Tappero J, Blandford J (2014) Global health and the US Centers for Disease Control and Prevention. Lancet (accepted for publication)
Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fududa K (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. JID 178:53–60
Sluijs JP, Craye M, Funtowicz S, Kloprogge P, Ravetz J, Risbey J (2005) Combining quantitative and qualitative measures of uncertainty in model-based environmental assessment: The NUSAP system. Risk Anal 25(2):481–492
Swayne DE, Perdue ML (2005) Public health risk from avian influenza viruses. Av Dis 49:317–327
Swayne DE (ed) (2008) Avian influenza. Blackwell Publishing, Ames
Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Rescuenco S, Gomez J, Chen LM, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney PJ, Bilbert AT, Chang J, Guo Z, Davis CT, Paulson JC, Stevens J, Rupprecht CE, Holmes EC, Wilson IA, Donis RO (2013) New world bats harbor diverse influenza a viruses. Plos Pathogens 9(10):e1003657
Tong S, Li Y, Rivailler P, Conrardy C, Castillo DAA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, Weil MR, Tang K, Rowe LA, Sammons S, Xu X, Frace M, Lindblade KA, Cox NJ, Anderson LJ, Rupprecht CE, Donis RO (2012) A distinct lineage of influenza a virus from bats. www.pnas.org/cgi/doi/10.1073/pnas.11162000109
Trock SC, Burke SA, Cox NJ (2012) Development of an influenza virologic risk assessment tool. Av Dis 56:1058–1061
USDA, National Poultry Improvement Plan (2007) http://www.aphis.usda.gov/vs/nahss/poultry/ai/avian_influenza_surveillance_plan_062907.pdf
USDA, National Surveillance Plan for Swine Influenza Virus in Pigs. 14 Jul 2010. http://www.aphis.usda.gov/animal_health/animal_dis_spec/swine/downloads/appendix_a_national_surv_plan.pdf
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaok Y (1992) Evolution and ecology of influenza a viruses. Microbiol Rev 56(1):152–179
WHO/OIE/FAO H5N1 Evolution Working Group (2014) Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1). Influenza Other Respir Viruses 8(3):384–388
World Health Organization (2014a) Human infection with influenza A(H7N) virus. http://who.int/influenza/human_animal_interface/influenza_h7n9/140225_H7N9RA_for_web_20140306FM.pdf?ua=1
World Health Organization (2014b) Influenza at the human-animal interface, monthly risk assessment summary. http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_5May14.pdf
World Health Organization (2013) Pandemic influenza risk management. http://www.who.int/influenza/preparedness/pandemic/GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013.pdf
Zimmer SM, Burke DS (2009) Historical perspective—emergence of influenza A (H1N1) viruses. NEJM 361(3):279–285
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cox, N.J., Trock, S.C., Burke, S.A. (2014). Pandemic Preparedness and the Influenza Risk Assessment Tool (IRAT). In: Compans, R., Oldstone, M. (eds) Influenza Pathogenesis and Control - Volume I. Current Topics in Microbiology and Immunology, vol 385. Springer, Cham. https://doi.org/10.1007/82_2014_419
Download citation
DOI: https://doi.org/10.1007/82_2014_419
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11154-4
Online ISBN: 978-3-319-11155-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)